Cardiac troponin T and illness severity in the very-low-birth-weight infant

Danielle N Lopes1, José M Moraes Ramos, Maria Elizabeth Lopes Moreira

  • 1Neonatal Intensive Care Unit, Clínica Perinatal Laranjeiras, 22240-002 Rio de Janeiro, Brazil.

Insights

Cardiac troponin T (cTnT) may indicate myocardial injury in very-low-birth-weight (VLBW) infants. Elevated cTnT levels were common in VLBW infants and linked to illness severity, suggesting its use as an early diagnostic marker.

Area of Science:

  • Neonatal Medicine
  • Pediatric Cardiology

Background:

  • Respiratory distress is common in very-low-birth-weight (VLBW) infants.
  • Myocardial injury may influence disease outcomes in VLBW infants.
  • Cardiac troponin T (cTnT) is a key marker for myocardial injury in adults but understudied in VLBW neonates.

Purpose of the Study:

  • To investigate the role of cTnT in VLBW infants.
  • To associate cTnT levels with clinical outcomes in this population.

Main Methods:

  • VLBW infants admitted to the NICU were enrolled.
  • Echocardiography and blood samples for cTnT were collected at 24 and 48 hours.
  • cTnT values >0.1 ng/mL were defined as positive.

Main Results:

  • 116 neonates had samples collected; median cTnT was 0.191 ng/mL at 24h and 0.293 ng/mL at 48h.
  • Positive cTnT was associated with patent ductus arteriosus (PDA), low gestational age (GA), and dopamine use.
  • Abnormal Doppler fluxometry and diuretic use showed protective effects.

Conclusions:

  • A high prevalence of elevated cTnT was observed in VLBW infants, correlating with illness severity.
  • cTnT may serve as a valuable early indicator of myocardial injury in VLBW neonates.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...